A.P. Pharma to Present at Merriman Curhan Ford's Annual Investor Summit on September 17
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Sept. 10, 2007--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceuticals company, today announced that John Barr, Ph.D., the Company's vice president of Research and Development, will present at the Merriman Curhan Ford 4th Annual Investor Summit on Monday, September 17, 2007, at 11:15 a.m. Pacific time.
This event will be held at the Mark Hopkins InterContinental Hotel in San Francisco.
More information about the conference can be found at: www.merrimanco.com
Interested parties can access a live audio webcast at www.appharma.com. An archived presentation will be available on the Company's Web site for 14 days.
About A.P. Pharma
A.P. Pharma is a specialty pharmaceutical company focused on the development of ethical (prescription) pharmaceuticals utilizing its proprietary polymer-based drug delivery systems. The Company's primary focus is the development and commercialization of its bioerodible injectable and implantable systems under the trade name Biochronomer(TM). Initial target areas of application for the Company's drug delivery technology include anti-nausea, pain management, anti-inflammation and DNA/RNAI applications. For further information visit the Company's web site at www.appharma.com.
CONTACT: A.P. Pharma, Inc.
President and Chief Executive Officer
Chief Financial Officer and Chief Operating Officer
Investor Relations Contacts:
Lippert/Heilshorn & Associates
SOURCE: A.P. Pharma, Inc.